Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFranchise Brands Regulatory News (FRAN)

Share Price Information for Franchise Brands (FRAN)

Share Price is delayed by 15 minutes
Get Live Data
142.00    0.00 (0.00%)
Bid:
143.00
Ask:
148.00
Spread: 5.00 (3.497%)
Market Cap: £272.19m
FRAN Live PriceLast checked at - London Stock Exchange

Intraday Franchise Brands Share Chart

SHARE REPURCHASE PROGRAMME

4 Jan 2019 07:00

RNS Number : 1739M
Franchise Brands PLC
04 January 2019
 

4 January 2019

 

FRANCHISE BRANDS PLC

("Franchise Brands", "the Group" or "the Company")

 

SHARE REPURCHASE PROGRAMME

 

Franchise Brands announces that from today until 30 June 2019 it will commence a programme to purchase ordinary shares of 0.5 pence each ("Ordinary Shares") in the Company, up to a value of £200,000 (the "Programme"). This is a continuation of the programme that commenced in 2018 and saw the Company purchase 200,000 Ordinary Shares into Treasury.

As announced on 12 December 2018, the Group, which is cash generative, intends to continue the share repurchase programme to offset the dilutive impact of employee share option awards, focusing on overall shareholder return. Ordinary Shares purchased under the Programme will therefore be held in Treasury to enable the Company to meet obligations arising from share option programmes. The total number of Ordinary Shares currently outstanding under option arrangements is 4,533,530 representing 5.8 per cent. of the Company's issued share capital.

The Programme will be conducted by the Company in accordance with and under the terms of the general authority granted by the Company's shareholders at the Company's Annual General Meeting on 25 April 2018 to purchase up to 7,773,203 shares. This authority will expire at the end of the next Annual General Meeting of the Company in 2019 or, if earlier, at the close of business on 25 July 2019 ("2018 Authority").

The Company has entered into an agreement with its joint broker, Dowgate Capital Stockbrokers Limited, to carry out on-market purchases of Ordinary Shares on its behalf under the Programme, including during any closed period of the Company which may fall during the period of the Programme. The Programme will also be conducted in accordance with the provisions of the Market Abuse Regulation 596/2014/EU dealing with buy-back programmes as necessary.

 

Enquiries:

 

Franchise Brands plc

+44 (0) 1562 826705

Stephen Hemsley, Executive Chairman

Chris Dent, Chief Financial Officer

Julia Choudhury, Corporate Development Director

 

 

Allenby Capital Limited (Nominated Adviser and Joint Broker)

 

+44 (0) 203 328 5656

Jeremy Porter/ Liz Kirchner

 

 

Dowgate Capital Stockbrokers (Joint Broker)

 

+44 (0) 203 903 7715

James Serjeant / Colin Climie

 

 

MHP Communications (Financial PR)

+44 (0) 203 128 8100

Katie Hunt

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
POSGMGGMRFFGLZM
Date   Source Headline
26th May 202612:58 pmRNSGrant of Options to director
18th May 20267:00 amRNSAppointment of new CFO & Group Delivery Director
30th Apr 20264:01 pmRNSResult of General Meeting
30th Apr 20264:00 pmRNSResult of Annual General Meeting
30th Apr 20267:00 amRNSAGM Statement and Q1 Trading Update
7th Apr 202612:29 pmRNSHolding(s) in Company
31st Mar 20265:13 pmRNSProposed Share Premium cancellation
31st Mar 20265:13 pmRNSAnnual Report and Accounts & Notice of AGM
27th Mar 20267:00 amRNSGrant of Options to directors
27th Mar 20267:00 amRNSDirectors’ dealings
26th Mar 20267:00 amRNSDirectors' dealings
25th Mar 20267:00 amRNSFinal Results
18th Mar 20267:00 amRNS-RInvestor Presentation via Investor Meet Company
11th Mar 20263:13 pmRNSHolding(s) in Company
11th Mar 20263:13 pmRNSHolding(s) in Company
5th Mar 202611:17 amRNSHolding(s) in Company
5th Mar 20267:00 amRNSNotice of Results
2nd Mar 20262:00 pmRNSHolding(s) in Company
28th Jan 20267:00 amRNSTrading Update
21st Jan 20263:00 pmRNSHolding(s) in Company
21st Jan 20262:55 pmRNSHolding(s) in Company
12th Jan 20267:00 amRNSHolding(s) in Company
12th Nov 20257:00 amRNSQ3 Trading Update
3rd Nov 20252:00 pmRNSHolding(s) in Company
16th Oct 20257:00 amRNSDirectors’ dealings
14th Oct 20257:00 amRNSEBT share purchase programme update
9th Oct 20253:48 pmRNSDirectors’ dealings – Replacement
9th Oct 20257:00 amRNSDirectors' dealings
1st Oct 20255:00 pmRNSDirectors’ dealings
29th Sep 20256:05 pmRNSDirectors’ dealings
23rd Sep 20252:00 pmRNSHolding(s) in Company
5th Aug 20258:46 amRNSUpdate on potential listing
31st Jul 20251:52 pmRNSGrant of Options to director
30th Jul 20257:00 amRNSInterim Results
21st Jul 20257:00 amRNS-RInvestor Presentation via Investor Meet Company
7th Jul 20257:00 amRNSNotice of Interim Results
23rd Jun 20257:00 amRNS-RInclusion in FTSE AIM UK 50 Index
28th May 202511:06 amRNSHolding(s) in Company
19th May 20257:00 amRNSMove to SETS
7th May 20253:00 pmRNSResult of AGM
7th May 20257:00 amRNSAGM Statement and Q1 Trading Update
9th Apr 202510:00 amRNSDirectors' dealings
8th Apr 202510:00 amRNSDirectors' dealings
7th Apr 202510:00 amRNSDirectors’ dealings
4th Apr 20254:00 pmRNSHolding(s) in Company
2nd Apr 20259:00 amRNS-RInvestor Presentation via Investor Meet Company
1st Apr 20252:19 pmRNSAnnual Report and Accounts & Notice of AGM
31st Mar 202510:30 amRNSDirector/PDMR Shareholding
27th Mar 20257:00 amRNSFinal Results
17th Mar 20257:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.